J. Ashley Booth, ASW, MS
Associate Social Worker
Los Angeles CA
My passion is to support clients as they navigate the path to health, presence, and fulfillment. My work is the synthesis of over a decade of personal growth, public education and advocacy, clinical research, harm reduction, and traditional psychotherapy while appreciating the intersection between our mind, body, and spiritual aspects. I integrate a psychedelically-informed approach to therapy incorporating trauma and somatic therapy, and parts work (IFS). My team and I provide ketamine-assisted psychotherapy for the treatment of depression, anxiety, and PTSD. I work with both people that are interested in exploring psychedelics to support them in achieving better mental health, as well as others that are using them for spiritual connection and life optimization.
Navigating the mysterious world of psychedelics & underground therapy can be very intimidating. While I do not provide guided sessions with illegal psychedelics nor make referrals to the underground, I do offer education, harm reduction, & preparation/integration therapy. I look forward to supporting you in making educated choices that are best for you.
Ashley Booth, ASW, MS, is a associate social worker (90016) offering Ketamine-Assisted Psychotherapy, somatic and mindfulness-based psychotherapy, as well as psychedelic integration. She left a career in environmental research in 2016 to pursue her passion for psychedelic education, advocacy, and therapy. She brings a wealth of knowledge from being steeped in the world of psychedelic advocacy and education as the founder of the Southern California psychedelic society, the Aware Project since 2016 and as a psychedelic integration coach through the organization she co-founded, InnerSpace Integration. She gained additional experience working as a psycho-spiritual retreat facilitator at the Crossroads Treatment Center in Mexico using ibogaine and 5-MeO-DMT. She is also a co-therapist on the Los Angeles Phase III team for the MAPS-sponsored clinical trial of MDMA-assisted psychotherapy for the treatment of PTSD.